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ABSTRACT 
Objective: To find out the correlation between various biochemical and clinical features of polycystic ovarian syn-
drome and to determine the best hormonal marker for the same. Material and Methods: The study included 100 pa-
tients of polycystic ovary syndrome (50 married & 50 unmarried) and a control group comprising of 50 women (25 
married & 25 unmarried) in the age group of 18 - 30 years. The pregnant females and those having hyperandrogenism 
due to any other endocrine disorders were excluded. Results: Mean age was 27.66 years in the married study group and 
25.46 years in the unmarried study group. About 71% of patients had oligomenorrhea. It significantly correlated with 
raised LH:FSH ratio and raised total testosterone levels. Body mass index was raised (>25 kg/m2) in 66.7% married and 
72.66% unmarried patients in study group and in 22% in control group. 95% of the patients in the study group and 4% 
in the control group were detected to have polycystic ovaries on ultrasonography. 62% of the patients had raised LH 
levels; total testosterone was elevated in 57.7%. The LH:FSH ratio was raised in 41% in study group patients more in 
the unmarried group 56% than in married group 26%. 20% of patients in the control group had an elevated LH:FSH 
ratio. Total testosterone level was elevated in 60% of our patients. None of the patient in the control group had elevated 
testosterone levels. About 31% of the patients in study group were hirsute. Conclusion: Hormonal values correlate well 
with polycystic ovarian syndrome and serum total testosterone served as the best hormonal marker for such patients. 
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1. Introduction 
Polycystic ovary syndrome (PCOS) is a common hetero- 
geneous endocrinological disorder that occurs in 5% to 
10% women in reproductive age group. It is the most 
prevalent endocrinopathy and common cause of infertile- 
ity [1]. Polycystic ovary syndrome consist of Chronic 
anovulation, menstrual disturbance, hyperandrogenism, 
polycystic ovaries, metabolic syndrome [2-4]. The cur- 
rent definition of PCOS is based on Rotterdam consensus 
meeting in 2003. It defines the syndrome as presence of 
any two of the following three criteria. 
1) Menstrual disturbance; oligomenorrhoea/anovulation. 
2) Clinical and/or biochemical signs of hyperandro- 
genism like acne, hirsutism etc., after other causes of 
hyperandrogenism have been ruled out. 
3) Ultrasound appearance of polycystic ovary as poly- 
cystic adnexae [5,6]. 
The etiology of this disorder is still uncertain, although 
it has been recognized in a familial pattern suggesting 
genetic etiology. The rate of PCOS in first degree relative is 
33% [7]. PCOS is associated with various endocrine ab-
normalities such as increased serum LH levels, increased 
ratio of LH:FSH, increased serum testosterone. Estima- 
tion of these hormones aids in the diagnosis. In PCOS 
ovary is enlarged >9 ml in volume, is smooth, sclerotic, 
has thickened capsular & subcapsular follicular cysts with 
atresia and hyperplastic theca and stroma [8]. Polycystic 
ovary contain 2-3 fold the normal number of follicles [8]. A 
classical ultrasound features of polycystic ovary syn- 
drome described by (Adam et al. 1985) which included 
enlarged ovary with presence of 10 or more cysts 2-8 
mm in diameter arranged either peripherally “string of 
pearls “around dense core of stroma or scattered throu- 
ghout an increased amount of stroma. Hyperandrogenism 
is the second common defining characteristic features of 
PCOS. The increased androgen levels are principally 
ovarian in origin, clinically commonly manifested by hir- 
sutism, and acne. 70% of patients with PCOS present with 
hirsutism [6]. Most of the late complications of PCOS 
are related to insulin resistance. In mild Insulin resis- 
tances, patients will have slightly elevated fasting serum 
insulin levels whereas in severe forms it may manifest with 
acanthosis nigricans [9]. Although all women with PCOS 
have evidence of insulin resistance it is more pronounced *Corresponding author. 
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in those with chronic anovulation [8]. 50% of patients with 
PCOS are obese [8,9]. Patients with PCOS have central 
obesity, increased deposition of fat around waist (an apple 
shaped instead of pear shaped). The obesity is android in 
type with increased waist to hip ratio & fat in anterior 
abdominal wall & mesentry [9]. Another risk of insulin 
resistance is the development of type 2 diabetes. More 
than 40% of women with PCOS demonstrate impaired 
glucose tolerance test, 10% have type 2 diabetes [1,9]. 
PCOS patients are at increased risk of cardiovascular 
disorders such as myocardial dysfunction, stroke and 
hypertension [9,10]. PCOS patients are at increased risk 
of developing endometrial carcinoma, due to increased 
circulating estrogen mainly estrone and unopposed action 
of progesterone [10]. These women also have increased 
chance of developing ovarian carcinoma, breast cancer 
and also carcinoma colon [9-11]. Our primary aim to 
conduct this study was to find out the correlation be- 
tween various biochemical and clinical features of poly- 
cystic ovarian syndrome and to determine the best hor- 
monal marker for the same. 
2. Material and Methods 
This prospective study included 100 patients of polycystic 
ovary syndrome (50 married & 50 unmarried) and a con- 
trol group comprising of 50 (25 married & 25 unmarried) 
women in the age group of 18 - 30 years. The Exclusion 
criteria were pregnancy and hyperandrogenism due to 
any other endocrine disorders. Patients were evaluated on 
outpatient basis and complete history was taken espe- 
cially menstrual and obstetric. Obstetric history included 
fertility status of the patient classified as fertile (had pre- 
vious pregnancy with no subsequent infertility), infertile 
(primary or secondary infertility of at least 1year dura- 
tion), unproven (pregnancy not attempted). Clinical exa- 
mination focused on anthropometry; height in cm, weight 
in kg. BMI > 25 kg/m2 was taken significant. Waist: hip 
ratio was calculated and a value of >0.88 was taken sig- 
nificant. Hirsutism was graded on the bases of Ferriman 
Galleway score. A Score > 8 was taken significant. Each 
patient underwent an ultrasound examination with a probe 
of 3.5 MHz. Cysts > 5 - 9 mm in diameter and >5 in sin-
gle ovary was taken significant. For hormonal assess-
ment blood sample was taken either in morning or after 
10 - 12 hrs fasting and analyzed for LH, FSH, and total 
testosterone. Samples were taken in early follicular phase 
(day 2/3 of cycle) in a women with normal menstrual 
rhythm and at random in women with oligomenorrhea. 
For FSH normal values were taken as 3 - 4.3 mIU/ml. 
For LH normal values were taken as 4.2 - 6.3 mIU/ml. 
LH:FSH ratio 2:1 was taken significant. 
3. Results and Analysis 
1) Age: The age in our study was 19 - 30 years. Mean 
age was 27.66 years in the married Study group and 
25.46 years in unmarried study group. 
2) BMI was raised >25 kg/m2 in 66.7% married and 
72.66% unmarried patients in study group and 22% in 
control group. 
3) Infertility: Prevalence of infertility in our study 
group was 74%. 
4) 71% of patients had oligomenorrhea. It was most 
common symptom in unmarried study group and second 
common complaint in married group. It was found to be 
significantly correlated with raised LH:FSH ratio and 
raised total testosterone levels. There was statistically sig- 
nificance of raised LH with oligomenorrhea. 
5) In our study weight gain was found in 16% of pa- 
tients in married group and 22% of the unmarried group 
it was the second commonest complaint seen in unmar- 
ried group. 
6) 31% patients were hirsute. 
7) 95% study group & 4% control group were detected 
to have polycystic ovaries on ultrasound (USG) exami-
nation. The sensitivity of USG in our study was 95%.and 
specificity 96%. 5% of our patients had normal ovaries 
on USG and 4% of normal females had PCO on USG. 
8) 63% patients in the study group had raised LH 
while as total testosterone was elevated in 57.7%. Hor- 
mone analysis was done on day 2 - 3 of the menstrual cycle. 
There was significant difference in hormone profile of 
the study and control group. Total Testosterone level was 
elevated in 60% of our patients. None of the patient in 
the control group had elevated testosterone levels. In our 
study positive predictive value of total testosterone was 
93.3% in patients with USG documented PCO. In our 
study LH was raised in 63% patients and 32% controls. 
The LH:FSH ratio was raised in 41% in study group pa- 
tients more in the unmarried group 56%. In married group 
26% patients had raised LH:FSH ratio. 20% of patients in 
the control group had an elevated LH:FSH ratio. 
4. Discussion 
The study group included 100 women and a control 
group of 50 women. The two were similar in their demo-
graphic profiles. The age in our study was 19 - 30 years. 
Mean age was 27.66 years in the married study group 
and 25.46 years in unmarried study group. Most of the 
previous studies focused on the similar age groups. Ah- 
med Abdul Nasr (2004) conducted a study on oligome- 
norrheic infertile women, & included patients with age 
group of 21 - 35 years [12]. Sharquie et al. 2007 included 
patients in the age group of 15 - 39 (mean 26.12 +/– 6.36) 
in their study [13]. Prevalence of PCOS in our study was 
19.7%. Fouzia Nazir et al. (1999) conducted a retrospec-
tive study on 52 women having polycystic ovary syn-
drome with fertility deprivation [14]. The prevalence of 
PCOS in their study was found 20.7% which is almost 
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similar to our study. Ahemad Aboul Nasr et al. (2004) 
conducted a prospective study on 50 patients to assess 
the morphological findings of the ovary based on trans- 
vaginal ultrasound in infertile oligomenorrheic women 
and their predictivity for endocrine sign of polycystic 
ovary syndrome. They found prevalence of PCOS in 
their study was 22%. R. Hart et al. (2004) concluded that 
PCOS perplexing endocrine disorder of women in their 
reproductive years with prevalence up to 10%. Abdul 
Ahad Zargar et al. (2005) conducted a study on 105 pa- 
tients < 45 yrs. They found prevalence of PCOS in their 
study was 5% - 10% [1]. Prevalence of infertility in our 
study was 74%. Fouzia Nazir et al. (1999) found primary 
infertility in 75% of patients [14]. Fouzia Haq et al.; 
(2007) evaluated a total of 508 patients for epidemiol- 
ogical features of PCOS. Frequency of PCOS in infertile- 
ity clinic was 17.6% [15]. In our study 71% of patients 
had oligomenorrhea. It was most common symptom in 
unmarried study group and second common complaint in 
married group. Fouzia Nazir et al. (1999) found 75% 
patients had oligomenorrhea in their study. Fouzia Adil 
et al. (2005) conducted a study on polycystic ovary syn- 
drome found oligomenorrhea in 79% [16]. H. Hassa et al. 
(2006) conducted a retrospective study to determine the 
hormonal and clinical profiles of polycystic ovarian syn- 
drome. 46% patients in their study had oligomenorrhea 
[17]. On correlating oligomenorrhea with hormone levels 
we found that it significantly correlated with raised 
LH:FSH ratio and raised total testosterone levels. There 
was statistical significance of raised LH with oligome- 
norrhea. Abdul Razak et al. (2007) [18] concluded that 
oligomenorrhea correlated with raised LH:FSH ratio [17]. 
95% study group & 4% control group were detected to 
have polycystic ovaries on USG. Sensitivity of USG in 
our study was 95% and specificity 96%. Sharquie et al. 
(2007) conducted a study to evaluate hormonal changes 
and pelvic sonography in patients of PCOS USG findings 
was positive in 80% of patients. Battacharya Dipankar et 
al. (2005) found USG to be sensitive but not specific. 5% 
of our patients had normal ovaries on USG and 4% of 
normal females had PCO on USG. Ahmed Aboul Nasr et 
al. (2004) conducted a study on 50 infertile oligomenor- 
rhric patients in the age group of 21 - 35 yrs. This study 
includes patients with infertility and oligomenorrhea only 
whereas our study include other parameters like weight 
gain, hirsutism as well. Polycystic ovaries was observed 
in 20% of normal control patients in this study. We ana-
lyzed patients who had PCO on USG with there hormo-
nal pattern. 63% had raised LH, total testosterone was 
elevated in 57.7%. Ahemad Aboul Nasr et al. (2004) 
conducted a prospective study to assess the morphologi- 
cal findings of the ovary based on transvaginal ultra- 
sound in infertile oligomenorrheic women and their pre- 
dictivity for endocrine sign of polycystic ovary syn- 
drome. The hormonal characteristics in the form of high 
LH, and high total testosterone showed statistically sig-
nificant difference between study and control group (P < 
0.05). About 31% patients were hirsute. Pache TD et al. 
(1993) conducted a study on 95 patients and found hir-
sutism in 63% patients. Fouzia Nazir (1999) conducted a 
study on diagnosis and management in fertility depriva-
tion in patients of PCOS found the hirsutism in 84.6% of 
patients. Abdul Razzak et al. (2007) found 64.49% pa-
tients hirsute. The weight gain was found in 16% of pa-
tients in married group and 22% of the unmarried group 
it was the second commonest complaint seen in unmar-
ried group .Fouzia Adil et al. (2005) found 50% of pa-
tients were obese. Fouzia haq et al. (2007) found obesity 
in 68.5% of patients. It was the commonest complaint 
seen in their study. Abdul Razzak et al. (2007) conducted 
a study and found 63.55% patients were obese. Sharquie 
et al. (2007) found obesity in 80% of patients. BMI was 
raised >25 kg/m2 in 66.7 % married and 72.66% unmar- 
ried patients in study group and 22% in control group. 
Fouzia Nazir et al. (1999) had 86.5% of patients with 
BMI > 25 kg/m2. Battacharya Dipankar et al. (2005) 
study had mean BMI of 28.98 kg/m2 (mean 25 - 39). 
Abdul Razzak et al. (2007) had 63.55% of patients with 
weight > 25kg/m2 in his study. The result of their study is 
almost similar to our study. Total Testosterone level was 
elevated in 60% of our patients. None of the patient in 
the control group had elevated testosterone levels. In our 
study positive predictive value of total testosterone was 
93.3% in patients with USG documented PCO. K. 
Michelmore et al. (1999) found elevated total testoster- 
one level in patients with PCOS. Analysis of their bio- 
chemical data showed that women with polycystic ova- 
ries had higher total testosterone levels than in women 
with normal ovaries (P = 0.03 Sharquie et al. (2007) 
found that total Testosterone levels were seen elevated in 
60% of patients in the study the results are in agreement 
with results obtained in our study. S. Robinbson et al. 
(1992) conducted a study to assess frequency of abnor- 
mal values for hormone measurement used in biochemi- 
cal diagnosis of PCOS They concluded that the total tes- 
tosterone hormone level was raised in 70% of patients 
They concluded total testosterone as best hormonal 
marker for the condition and was the single most diag- 
nostic test. Total testosterone was the best hormonal 
marker in our study as well. LH was raised in 63% pa-
tients and 32% controls. Ahmed Aboul Nasr et al. (2004) 
concluded that LH elevated in 86.7% of patients. Robin- 
sons et al. 1992 found LH abnormality in 35% of patients 
in our study raised LH correlated significantly with oli-
gomenorrhea. J. Holte et al. (1994) study found mean 
concentration of LH to be elevated in patients with PCOS. 
LH:FSH ratio was raised in 41% in study group patients 
more in the unmarried group 56%. In married group 26% 
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patients had raised LH:FSH ratio. 20% of patients in the 
control group had an elevated LH:FSH ratio. Fouzia Na- 
zir et al. (1999) found high LH:FSH ratio in 75% of pa- 
tients. Fouzia Aadil et al. (2005). 67.42% patients were 
having elevated ratio LH:FSH in their study. Ratio was 
significant and abnormally raised in 41% - 44% of pa-
tients in study of Robinson Set et al. (1992). The results 
are similar to the results derived from our study. Bat- 
tacharya Dipankar et al. (2005) found LH:FSH ratio in- 
creased in 55.55% of patients. Sharquie et al. (2007), 
60% of patients were having raised LH:FSH ratio. 
5. Conclusions 
From the present study we can draw the following con-
clusions for our population: Raised LH has statistically 
significant correlation with oligomenorrhea. It also cor-
related significantly with raised LH:FSH ratio and in-
creased testosterone levels. Total Testosterone which was 
elevated in 60% of patients in PCOS proved to be the 
best hormonal marker for patients of PCOS. 
However a larger study is required to exactly find the 
prevalence of disease as well as the correlation of differ-
ent parameters commonly found in this disease. 
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